abstract |
It is disclosed that compounds which are analogs of EK 228 of general formula (1) or isomer thereof and pharmaceutically acceptable salts thereof inhibit HDAC, wherein R1, R2, R3 and R4 are identical or different and represent an amino acid side chain fraction and each R 6 is identical or different and represents hydrogen or C 1 -C 4 alkyl. |